OpenAI’s Investor Memo: Anthropic on a ‘Meaningfully Smaller Curve’
CNBC: OpenAI shareholder memo claims Anthropic operates on a meaningfully smaller development curve — OpenAI’s ramp ahead even vs Anthropic’s high-end reported range, citing compute advantage. Read as competitive narrative for capital, not an audited compute census.

Investor memos are where labs fight without shipping a model. OpenAI’s April message is blunt: Anthropic is on a smaller scaling curve — a financing narrative as much as a scientific claim.
CNBC (April 9), with Bloomberg cross-coverage, reported OpenAI sent shareholders a memo blasting rival Anthropic for “operating on a meaningfully smaller curve.” OpenAI says its ramp is materially ahead and widening even at the high end of Anthropic’s reported range, emphasizing computing advantage and deployment speed. Context in coverage: Anthropic momentum (Claude, Glasswing) vs OpenAI scale claims, including prior funding figures cited in secondary reporting (e.g. large round / high valuation references).
What the memo asserts (as reported)
- Anthropic on a “meaningfully smaller curve.”
- OpenAI ramp ahead vs Anthropic’s high-end metrics.
- Compute / infrastructure lead as differentiator.
Moving rivalry into shareholder communications is the procedural novelty — product launches alone no longer carry the narrative.
Claims vs checks
Quotations and framing are CNBC/Bloomberg reporting of a private memo — not a public OpenAI PDF with full exhibits. Curve comparisons depend on undisclosed definitions (FLOPs, revenue, tokens, users). Prior funding/valuation figures in secondary coverage are context, not independently re-audited here.
Limits
- Full memo not public; selective leaks shape the story.
- No third-party compute ledger attached.
- Competitive trash-talk is not a substitute for independent model indexes.
Sources
- CNBC: “OpenAI slams Anthropic in memo to shareholders as rival gains momentum” (April 9, 2026).
- Bloomberg reporting on the memo (cross-referenced).
- OpenAI shareholder communications context (prior funding/valuation references in coverage).